Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Genitourinary Cancers
•
Medical Oncology
What is the best management for a patient with advanced renal medullary carcinoma?
Answer from: Medical Oncologist at Academic Institution
Very interesting regarding case reports of long term responses with proteasome inhibitors. Thanks for sharing.
Sign in or Register to read more
6353
Related Questions
What is your preferred initial systemic therapy approach to metastatic clear cell adenocarcinoma of the urethra (CCAU)?
How would you manage T3N0M0 sarcomatoid carcinoma of the prostate with Adenosquamous differentiation s/p prostatectomy?
Would the presence of only mature teratoma on orchiectomy specimen lead you to consider upfront RPLND followed by adjuvant chemotherapy as opposed to upfront chemotherapy in a patient with bulky para-aortic nodal disease (cN3) and AFP/beta-HCG elevation?
For an older patient with hormone-sensitive high-volume, high-risk prostate cancer with metastases to bone who developed toxicity with enzalutamide, what other oral AR blocker would you offer?
Would you add whole-pelvis radiation as MDT (metastasis-directed therapy) in a patient with 1 pelvic node and 2 osseous metastatic sites for castrate-resistant prostate cancer?
How do you interpret NIAGARA efficacy given that adjuvant nivolumab was not administered in the comparator arm?
What chemotherapy regimen do you use for de novo metastatic squamous cell carcinoma of penile urethra?
Would you recommend patients with newly diagnosed bladder cancer to discontinue SGLT2 inhibitors?
Is there any evidence for combining surgery and XRT +/- ADT for treatment of localized high risk prostate cancer?
How do you manage enfortumab vedotin related DKA that is refractory to standard therapy (insulin, fluids, etc)?